How Wound Care Practitioners Report MIPS — and Which Quality Measures Actually Apply
Most wound care practitioners who report the Merit-based Incentive Payment System do it through a Qualified Clinical Data Registry, and the reason is simple: the general MIPS quality measure inventory was not built with wound care in mind. Pick six measures off the standard list and a wound care physician ends up reporting on things that have little to do with what happens in the exam room. The specialty solved this by building its own measures. Here is how the reporting actually works, and what is about to change.
Who in a wound care practice is actually required to report?
MIPS participation turns on the low-volume threshold, and the test is stricter than most people assume. For the 2026 performance year, a clinician or group is required to report only if they exceed all three elements — more than $90,000 in Medicare Part B allowed charges, more than 200 Part B patients, and more than 200 covered professional services — and they must exceed all three during both segments of the determination period. Fall at or below any single element in either segment and reporting is not required, though opting in remains available. CMS publishes each clinician’s status by NPI, and the eligibility criteria CMS publishes each year spell out how the group-level calculation differs from the individual one. This matters for mobile and hospital-based practitioners in particular, because a clinician can be exempt at one TIN and required at another.
The stakes are the same for everyone who does have to report. The performance threshold is 75 points, held there through the 2028 performance year, and 2026 performance sets the 2028 payment adjustment — which can swing up to nine percent in either direction.
What does traditional MIPS require in 2026?
CMS finalized its 2026 Quality Payment Program policies with the category weights unchanged: Quality at 30 percent, Cost at 30 percent, Promoting Interoperability at 25 percent, and Improvement Activities at 15 percent.
Under traditional MIPS, Quality means six measures collected across the full calendar year, at least one of which must be an outcome measure. Improvement Activities means two activities performed for at least 90 continuous days, or one for clinicians with special status. Promoting Interoperability means the full measure set over a continuous 180-day period. Cost requires no submission at all — CMS calculates it from claims, which is precisely why it deserves more attention than it usually gets.
Which quality measures actually apply to wound care?
The wound care-specific measures exist because the specialty built them. In 2010, Intellicure developed the first quality measures specific to wound care practice, later approved and adopted by CMS for its Quality Payment Programs. Those measures are now stewarded by the US Wound Registry and developed in conjunction with the Alliance of Wound Care Stakeholders, the Undersea and Hyperbaric Medical Society, and the American Podiatric Medical Association.
For 2026 there are eight wound care measures the registry offers this year, covering nutritional assessment, non-invasive arterial assessment, adequate compression for venous leg ulcers, adequate off-loading of diabetic foot ulcers, and healing or closure of diabetic foot ulcers, venous leg ulcers, and pressure ulcers. New for 2026 is USWR37, objective measurement of wound surface area using AI-based imaging. The closure measures matter structurally as well as clinically, because they are outcome measures — the category traditional MIPS requires at least one of.
Knowing which measures apply is the easy part. Meeting them consistently, across every encounter, is where scores are won or lost. The Individual Quality Scorecard was the first and only tool that identifies quality measures not being met within each individual patient encounter, which turns quality reporting from a year-end reconciliation into something a clinician can correct while the patient is still in the room. Paired with guidance surfaced inside the chart, the effect on a final score is direct.
“Intellicure’s Clinical Decision Support tools improved my Quality Scores and helped avoid a MIPS penalty.”
— Sherrill White-Wolfe, Director of Wound Care, CHI St. Luke’s, The Woodlands, TX
What does a QCDR do that a qualified registry doesn’t?
Both are third-party intermediaries approved by CMS to submit MIPS data. The difference is measure development. A qualified registry reports the measures CMS already publishes. A Qualified Clinical Data Registry is an entity with clinical expertise in both medicine and quality measurement that collects data for patient and disease tracking — and it can develop its own measures and submit them to CMS for approval. That authority is the only reason wound care has measures describing wound care. A QCDR also supplies performance feedback during the year and can offer improvement activities designed around wound care practice rather than generic ones.
Why is the Cost category the one to watch?
Cost is 30 percent of the final score and requires nothing from the practice, which makes it easy to ignore until it costs money. CMS is developing a Non-Pressure Ulcers episode-based cost measure — covering diabetic foot ulcers, venous leg ulcers, arterial ulcers, and chronic ulcers generally — and field tested it from January 29 through February 27, 2026. It is not scored and does not affect payment yet. But the episode-based cost measures still in development are worth tracking now, because attribution rules written without wound care input are considerably harder to fix after adoption than before it.
What happens if traditional MIPS goes away?
There are 27 MIPS Value Pathways available for 2026, including six new ones for diagnostic radiology, interventional radiology, neuropsychology, pathology, podiatry, and vascular surgery. None of the 27 is built around wound care. That was a manageable gap while MVPs were optional. In the proposed CY 2027 Physician Fee Schedule, released July 14, 2026, CMS proposes to sunset traditional MIPS after the 2028 performance year and make MVPs the primary reporting pathway. The comment period closes September 14, 2026.
For now, traditional MIPS with QCDR measures remains the workable route for wound care, and MVP registration for practices testing that path closes November 30. But the practices that will handle the transition well are the ones already capturing measure data as a byproduct of documentation rather than as a separate reporting project. Whichever pathway survives, the underlying requirement is the same: the chart has to contain the evidence.
